TY - JOUR
T1 - Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury
AU - Tonnus, Wulf
AU - Meyer, Claudia
AU - Steinebach, Christian
AU - Belavgeni, Alexia
AU - von Mässenhausen, Anne
AU - Gonzalez, Nadia Zamora
AU - Maremonti, Francesca
AU - Gembardt, Florian
AU - Himmerkus, Nina
AU - Latk, Markus
AU - Locke, Sophie
AU - Marschner, Julian
AU - Li, Wenjun
AU - Short, Spencer
AU - Doll, Sebastian
AU - Ingold, Irina
AU - Proneth, Bettina
AU - Daniel, Christoph
AU - Kabgani, Nazanin
AU - Kramann, Rafael
AU - Motika, Stephen
AU - Hergenrother, Paul J.
AU - Bornstein, Stefan R.
AU - Hugo, Christian
AU - Becker, Jan Ulrich
AU - Amann, Kerstin
AU - Anders, Hans Joachim
AU - Kreisel, Daniel
AU - Pratt, Derek
AU - Gütschow, Michael
AU - Conrad, Marcus
AU - Linkermann, Andreas
N1 - Funding Information:
We would like to cordially thank Cemile Jakupoglu and Markus Brielmeier for help in generating the Fsp1−/−-mice, Romy Opitz for expert technical assistance, and Renata Drtina for critically reading the manuscript. We thank the histology facility, the FACS facility, as well as the light microscopy facility at the CMCB Dresden, in particular Hella Hartmann, for the expert help. Work in the Linkermann Lab is funded by the Medical Clinic 3, University Hospital Carl Gustav Carus Dresden, Germany, and supported by the SFB-TRR 205, SFB-TRR 127, SPP2306, and the international research training group (IRTG) 2251. This work was supported by the German Research Foundation (DFG) (Heisenberg-Professorship to A.L. (project number 324141047), GE2845/1-1 to F.G., AN372/24-1 to H.J.A. and KR3363/3-1 to N.K.). We received further funding for this project from the transCampus initiative of S.R.B. Work in the Conrad Lab is funded by the DFG (CO 291/5-2; CO 291/7-1; PR 1752/3-1), the German Federal Ministry of Education and Research (BMBF) VIP + program 03VP04260, the Helmholtz Validation Fund (0042), the Ministry of Science and Higher Education of the Russian Federation (075-15-2019-1933), the Else Kröner-Fresenius-Stiftung, the Bavarian Ministry of Economic Affairs, Regional Development and Energy (StMWi), and M.C. has further received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No. GA 884754). K.A. and C.D. received funding by the SFB 1350 TP C2.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12/1
Y1 - 2021/12/1
N2 - Acute kidney injury (AKI) is morphologically characterized by a synchronized plasma membrane rupture of cells in a specific section of a nephron, referred to as acute tubular necrosis (ATN). Whereas the involvement of necroptosis is well characterized, genetic evidence supporting the contribution of ferroptosis is lacking. Here, we demonstrate that the loss of ferroptosis suppressor protein 1 (Fsp1) or the targeted manipulation of the active center of the selenoprotein glutathione peroxidase 4 (Gpx4cys/-) sensitize kidneys to tubular ferroptosis, resulting in a unique morphological pattern of tubular necrosis. Given the unmet medical need to clinically inhibit AKI, we generated a combined small molecule inhibitor (Nec-1f) that simultaneously targets receptor interacting protein kinase 1 (RIPK1) and ferroptosis in cell lines, in freshly isolated primary kidney tubules and in mouse models of cardiac transplantation and of AKI and improved survival in models of ischemia-reperfusion injury. Based on genetic and pharmacological evidence, we conclude that GPX4 dysfunction hypersensitizes mice to ATN during AKI. Additionally, we introduce Nec-1f, a solid inhibitor of RIPK1 and weak inhibitor of ferroptosis.
AB - Acute kidney injury (AKI) is morphologically characterized by a synchronized plasma membrane rupture of cells in a specific section of a nephron, referred to as acute tubular necrosis (ATN). Whereas the involvement of necroptosis is well characterized, genetic evidence supporting the contribution of ferroptosis is lacking. Here, we demonstrate that the loss of ferroptosis suppressor protein 1 (Fsp1) or the targeted manipulation of the active center of the selenoprotein glutathione peroxidase 4 (Gpx4cys/-) sensitize kidneys to tubular ferroptosis, resulting in a unique morphological pattern of tubular necrosis. Given the unmet medical need to clinically inhibit AKI, we generated a combined small molecule inhibitor (Nec-1f) that simultaneously targets receptor interacting protein kinase 1 (RIPK1) and ferroptosis in cell lines, in freshly isolated primary kidney tubules and in mouse models of cardiac transplantation and of AKI and improved survival in models of ischemia-reperfusion injury. Based on genetic and pharmacological evidence, we conclude that GPX4 dysfunction hypersensitizes mice to ATN during AKI. Additionally, we introduce Nec-1f, a solid inhibitor of RIPK1 and weak inhibitor of ferroptosis.
UR - http://www.scopus.com/inward/record.url?scp=85111097567&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111097567&partnerID=8YFLogxK
U2 - 10.1038/s41467-021-24712-6
DO - 10.1038/s41467-021-24712-6
M3 - Article
C2 - 34285231
AN - SCOPUS:85111097567
SN - 2041-1723
VL - 12
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 4402
ER -